Your browser doesn't support javascript.
loading
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza, Mansoor Raza; Åvall Lundqvist, Elisabeth; Birrer, Michael J; dePont Christensen, Rene; Nyvang, Gitte-Bettina; Malander, Susanne; Anttila, Maarit; Werner, Theresa L; Lund, Bente; Lindahl, Gabriel; Hietanen, Sakari; Peen, Ulla; Dimoula, Maria; Roed, Henrik; Ør Knudsen, Anja; Staff, Synnöve; Krog Vistisen, Anders; Bjørge, Line; Mäenpää, Johanna U.
Afiliação
  • Mirza MR; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: mansoor.raza.mirza@regionh.dk.
  • Åvall Lundqvist E; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Linköping University, Linköping, Sweden; Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Birrer MJ; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  • dePont Christensen R; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Research Unit of General Practice University of Southern Denmark, Odense, Denmark.
  • Nyvang GB; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Odense University Hospital, Odense, Denmark.
  • Malander S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Lund University Hospital, Lund, Sweden.
  • Anttila M; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Kuopio University Hospital, Kuopio, Finland.
  • Werner TL; University of Utah, Salt Lake City, UT, USA.
  • Lund B; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Aalborg University Hospital, Aalborg, Denmark.
  • Lindahl G; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Linköping University, Linköping, Sweden.
  • Hietanen S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Turku University Hospital, Turku, Finland.
  • Peen U; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Herlev University Hospital, Herlev, Denmark.
  • Dimoula M; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Sahlgrenska University Hospital, Göteborg, Sweden.
  • Roed H; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ør Knudsen A; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Odense University Hospital, Odense, Denmark.
  • Staff S; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology and Tays Cancer Centre, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland.
  • Krog Vistisen A; Aalborg University Hospital, Aalborg, Denmark.
  • Bjørge L; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway; Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Mäenpää JU; Nordic Society of Gynaecological Oncology, Copenhagen, Denmark; Department of Obstetrics and Gynecology and Tays Cancer Centre, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland.
Lancet Oncol ; 20(10): 1409-1419, 2019 10.
Article em En | MEDLINE | ID: mdl-31474354
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piperidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Endometrioide / Indazóis / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piperidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Endometrioide / Indazóis / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article